Table 4 Characteristics of blaNDM−1 harbouring P. aeruginosa isolates
Characteristics | Patient-1 | Patient-2 | Patient 3 |
|---|---|---|---|
Isolate Number | P1 | P3 | P6 |
Age(yr)/Sex | 57y/Female | 59y/Male | 30y/Female |
Hospital location | ICU | ICU | ICU |
Specimen source | Tracheal swab | Urine | Pus |
Underlying disease/diagnosis | Sub-dural haemorrhage | Post stroke seizure | TB meningitis, transverse myelitis and communicating hydrocephalus |
Co-morbid conditions | Diabetes& hypertension | Diabetes& hypertension | None |
Antimicrobials used prior to detection of blaNDM−1 | Cefotaxime, gentamicin and ciprofloxacin | Flucloxacillin, meropenem and ciprofloxacin | Nitrofurantoin, ceftriaxone and flucloxacillin |
Antibiotics tested | |||
Amikacin | R | R | R |
Gentamicin | R | R | R |
Ciprofloxacin | R | R | R |
Imipenem | R | R | R |
Meropenem | R | R | R |
Piperacillin | R | R | R |
Piperacillin/tazobactam | R | R | R |
Aztreonam | R | R | R |
Ofloxacin | R | R | R |
Levofloxacin | R | R | R |
Ceftazidime | R | R | R |
Cefepime | R | R | R |
Colistin | S | S | S |